Browse by author
Lookup NU author(s): Dr Christopher DuncanORCiD, Professor Sophie Hambleton
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
STAT2 is distinguished from other STAT family members by its exclusive involvement in type I and III interferon (IFN-I/III) signaling pathways, and its unique behavior as both positive and negative regulator of IFN-I signaling. The clinical relevance of these opposing STAT2 functions is exemplified by monogenic diseases of STAT2. Autosomal recessive STAT2 deficiency results in heightened susceptibility to severe and/or recurrent viral disease, whereas homozygous missense substitution of the STAT2-R148 residue is associated with severe type I interferonopathy due to loss of STAT2 negative regulation. Here we review the clinical presentation, pathogenesis, and management of these disorders of STAT2.
Author(s): Duncan CJA, Hambleton S
Publication type: Review
Publication status: Published
Journal: Journal of Clinical Immunology
Year: 2021
Volume: 41
Issue: 7
Pages: 1446-1456
Print publication date: 06/10/2021
Online publication date: 26/08/2021
Acceptance date: 03/08/2021
ISSN (print): 0271-9142
ISSN (electronic): 1573-2592
URL: https://doi.org/10.1007/s10875-021-01118-z
DOI: 10.1007/s10875-021-01118-z
PubMed id: 34448086